Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE for Affect lability: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 2,065 adverse event reports in the FDA FAERS database where DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE was used for Affect lability.

Most Reported Side Effects for DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE

Side Effect Reports % Deaths Hosp.
Death 2,780 52.4% 2,780 20
Product use in unapproved indication 211 4.0% 28 15
Off label use 157 3.0% 8 8
Drug ineffective 137 2.6% 7 8
Therapy interrupted 130 2.5% 5 10
Dizziness 117 2.2% 1 11
Product use issue 114 2.2% 35 9
Diarrhoea 97 1.8% 1 9
Fall 91 1.7% 13 29
Inability to afford medication 86 1.6% 0 2
Therapeutic response unexpected 85 1.6% 4 7
Dysphagia 84 1.6% 9 3
Somnolence 82 1.6% 4 8
Nausea 73 1.4% 0 11
Disease recurrence 72 1.4% 6 8

Other Indications for DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE

Product used for unknown indication (2,689) Crying (85) Dementia (56) Amyotrophic lateral sclerosis (54) Depression (44) Dementia alzheimer's type (43) Anxiety (33) Craniocerebral injury (33) Agitation (29) Cerebrovascular accident (29)

Other Drugs Used for Affect lability

RISPERIDONE (112) QUETIAPINE (33) ARIPIPRAZOLE (26) OLANZAPINE (26) LAMOTRIGINE (21) SERTRALINE (18) LITHIUM (13) FLUOXETINE (11) PALIPERIDONE (11) VALPROATE (10)

Related Pages

DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Full Profile All Affect lability Drugs DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Demographics DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Timeline